Tag : biotechnology company

Clinical Research, Pharma & Healthcare Financing

XellSmart Gets FDA Clearance for 3 Phase I INDs in CNS Cell Therapies

PR Newswire
XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell therapies. To date, the company has...
Clinical Research, Pharma & Healthcare Financing

Nuclera Enhances eProtein Discovery for Membrane Protein Production

Business Wire
Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow...
Healthcare Infrastructure, Operations & Supply Chain

OS Therapies Gets Patent Allowance for OST-HER2 Manufacturing

Business Wire
Patent Term Adjustment will provide market exclusivity in the United States into 2040 for all therapeutic indications OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology...
Clinical Research, Pharma & Healthcare Financing

Navega Therapeutics Gets CIRM Grant for Chronic Pain Treatment

PR Newswire
 Next-generation AAV gene therapy targets intractable chronic pain Navega Therapeutics, a biotechnology company developing epigenetic gene therapies, today announced the receipt of a $4M Translational Science grant...